Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer’s Disease Spectrum
Authors:
- Stefan J. TeipelSTStefan J. Teipel
- Martin DyrbaMDMartin Dyrba
- Tommaso BallariniTBTommaso Ballarini
- Frederic BrosseronFBFrederic Brosseron
- Davide BrunoDavide Bruno
- Nicoleta-Carmen CosmaNCNicoleta-Carmen Cosma
- Peter DechentPDPeter Dechent
- Emrah DüzelEDEmrah Düzel
- Michael EwersMichael Ewers
- Klaus FliessbachKFKlaus Fliessbach
Open Access
- 1 February 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 85 (3) , 1267-1282
Abstract
Background: Inflammation has been described as a key pathogenic event in Alzheimer’s disease (AD), downstream of amyloid and tau pathology. Preclinical and clinical data suggest that the cholinergic basal forebrain may moderate inflammatory response to different pathologies. Objective: To study the association of cholinergic basal forebrain volume and functional connectivity with measures of neuroinflammation in people from the AD spectrum. Methods: We studied 261 cases from the DELCODE cohort, including people with subjective cognitive decline, mild cognitive impairment, AD dementia, first degree relatives, and healthy controls. Using Bayesian ANCOVA, we tested associations of MRI indices of cholinergic basal forebrain volume and functional connectivity with cerebrospinal fluid (CSF) levels of sTREM2 as a marker of microglia activation, and serum levels of complement C3. Using Bayesian elastic net regression, we determined associations between basal forebrain measures and a large inflammation marker panel from CSF and serum. Results: We found anecdotal to moderate evidence in favor of the absence of an effect of basal forebrain volume and functional connectivity on CSF sTREM2 and serum C3 levels both in Aβ42/ptau-positive and negative cases. Bayesian elastic net regression identified several CSF and serum markers of inflammation that were associated with basal forebrain volume and functional connectivity. The effect sizes were moderate to small. Conclusion: Our data-driven analyses generate the hypothesis that cholinergic basal forebrain may be involved in the neuroinflammation response to Aβ42 and phospho-tau pathology in people from the AD spectrum. This hypothesis needs to be tested in independent samples.Keywords
This publication has 62 references indexed in Scilit:
- Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's diseaseInternational Journal of Neuroscience, 2013
- CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy eldersTranslational Psychiatry, 2013
- CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's DiseasePLOS ONE, 2012
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's DiseaseBiological Psychiatry, 2010
- Neuronal MCP‐1 Mediates Microglia Recruitment and Neurodegeneration Induced by the Mild Impairment of Oxidative MetabolismBrain Pathology, 2010
- Neuroinflammatory processes in Alzheimer’s diseaseJournal of Neural Transmission, 2010
- In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseasesJournal of Neuroinflammation, 2010
- Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's diseaseNeurochemistry International, 2005
- Regularization and Variable Selection Via the Elastic NetJournal of the Royal Statistical Society Series B: Statistical Methodology, 2005
- Distribution pattern and functional state of complement proteins and α-antichymotrypsin in cerebral β/A4 deposits in Alzheimer's diseaseResearch in Immunology, 1992